Marian Nakada - Profile and Investment Details

Investor Profile

Marian Nakada is a Venture Capital, Corporate Venture Capital based in Cambridge, United States with a diverse investment portfolio that includes companies such as Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia, Direct Flow Medical, Pulmocide, NovoCure, Syntaxin, Astute Medical, TopiVert, iScience Interventional, Padlock Therapeutics, Protagonist Therapeutics, Acclarent, Brainsgate, Inspire Medical Systems, Aduro BioTech, Pronota, Mitralign, GI Dynamics, GetWellNetwork, Inc., ImaCor, ViaCyte, ReVision Optics, Arbor Surgical Technologies, Binx Health, Thesan Pharmaceuticals, Genocea Biosciences, Rodin Therapeutics, Zeo, Nevro, La Lumiere, Inivata, Willow, 23andMeGrail, Optherion, Breathe Technologies, Neotract, InSound Medical, OptiScan Biomedical, Celladon, Aquinox Pharmaceuticals, Navitor Pharmaceuticals, Vedanta Biosciences, PhaseBio Pharmaceuticals, Intio, PowerVision, Cala Health, Neurosearch, Merus, Biocartis, CVRx, NeuroPace, Fusion Pharmaceuticals, Molecular Partners, Biolex Therapeutics, Sleep Solutions, Spinal Modulation, Neuron Systems, 7TM Pharma, Tengion, . Over time, Marian Nakada has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Marian Nakada is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Hospitals, Wellness, Women Founded, Design, Life Science, Medical Technologies, Mobile, Manufacturing, Biotechnology, Medical Devices, Neuroscience, Clinical Trials, Health Diagnostics, Medical, B2B, Therapeutics, Health Tech, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Marian Nakada, as their portfolio suggests a familiarity and interest in this area.

Understanding Marian Nakada’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.